Education
About Us
Working with TipRanks
Follow Us
Aspen Pharmacare (APNHY)
OTHER OTC:APNHY
APNHY Stock Chart & Stats
$5.58
$0.00(0.00%)
At close: 4:00 PM EST
$5.58
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$5.43 - $10.06
Previous CloseN/A
Volume14.00
Average Volume (3M)710.00
Market Cap
$2.40B
Enterprise Value$4.66B
Total Cash (Recent Filing)$6.80B
Total Debt (Recent Filing)$35.47B
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Mar 05, 2026EPS EstimateN/A
Last Dividend Ex-Date
Oct 03, 2025Dividend Yield2.19%
Share Statistics
EPS (TTM)-0.42
Shares Outstanding446,252,320
10 Day Avg. Volume0
30 Day Avg. Volume710
Financial Highlights & Ratios
PEG Ratio0.39
Price to Book (P/B)0.63
Price to Sales (P/S)1.23
P/FCF Ratio512.59
Enterprise Value/Market Cap1.94
Enterprise Value/Revenue0.10
Enterprise Value/Gross Profit0.23
Enterprise Value/Ebitda0.43
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aspen Pharmacare News
APNHY FAQ
What was Aspen Pharmacare’s price range in the past 12 months?
Aspen Pharmacare lowest stock price was $5.43 and its highest was $10.06 in the past 12 months.
What is Aspen Pharmacare’s market cap?
Aspen Pharmacare’s market cap is $2.40B.
When is Aspen Pharmacare’s upcoming earnings report date?
Aspen Pharmacare’s upcoming earnings report date is Mar 05, 2026 which is in 117 days.
How were Aspen Pharmacare’s earnings last quarter?
Aspen Pharmacare released its earnings results on Sep 03, 2025. The company reported -$0.425 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.425.
Is Aspen Pharmacare overvalued?
According to Wall Street analysts Aspen Pharmacare’s price is currently Overvalued.
Does Aspen Pharmacare pay dividends?
Aspen Pharmacare pays a Annually dividend of $0.122 which represents an annual dividend yield of 2.19%. See more information on Aspen Pharmacare dividends here
What is Aspen Pharmacare’s EPS estimate?
Aspen Pharmacare’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aspen Pharmacare have?
Aspen Pharmacare has 446,252,320 shares outstanding.
What happened to Aspen Pharmacare’s price movement after its last earnings report?
Aspen Pharmacare reported an EPS of -$0.425 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.321%.
Which hedge fund is a major shareholder of Aspen Pharmacare?
Currently, no hedge funds are holding shares in APNHY
Aspen Pharmacare Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.29%
12-Months-Change
Fundamentals
Return on Equity
-1.18%
Trailing 12-Months
Asset Growth
0.34%
Trailing 12-Months
Company Description
Aspen Pharmacare
Aspen Pharmacare is a leading global specialty and generic pharmaceutical company headquartered in South Africa. It operates across various sectors including pharmaceuticals, consumer healthcare, and active pharmaceutical ingredients (APIs). The company focuses on providing high-quality, affordable medicines in therapeutic areas such as oncology, anesthesia, and critical care, along with a range of consumer health products. Aspen is recognized for its extensive portfolio of over 1,000 products and its commitment to improving patient access to essential medications worldwide.
APNHY Company Deck
APNHY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong growth in the Commercial Pharma segment and successful product launches, particularly in emerging markets. However, the loss of a key contract, adverse currency impacts, increased tax burdens, and challenges in the Manufacturing segment notably affected the overall financial performance.View all APNHY earnings summariesTechnical Analysis
Perrigo Company
―
Supernus Pharmaceuticals
―
HUTCHMED
―
Amneal Pharmaceuticals
―
Alvotech
―
Ownership Overview
―
Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---